These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10602517)

  • 21. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
    Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
    Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct regions of allelic loss on 13q in prostate cancer.
    Cooney KA; Wetzel JC; Merajver SD; Macoska JA; Singleton TP; Wojno KJ
    Cancer Res; 1996 Mar; 56(5):1142-5. PubMed ID: 8640774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of a novel tumor suppressor gene associated with human oral cancer on chromosome 4q25.
    Wang XL; Uzawa K; Imai FL; Tanzawa H
    Oncogene; 1999 Jan; 18(3):823-5. PubMed ID: 9989834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade.
    Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Sandstedt B; Steineck G
    Clin Cancer Res; 2000 Feb; 6(2):610-5. PubMed ID: 10690546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer.
    Kagan J; Liu J; Stein JD; Wagner SS; Babkowski R; Grossman BH; Katz RL
    Oncogene; 1998 Feb; 16(7):909-13. PubMed ID: 9484782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
    Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
    Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of tumor metastasis suppressor region on the short arm of human chromosome 20.
    Goodarzi G; Mashimo T; Watabe M; Cuthbert AP; Newbold RF; Pai SK; Hirota S; Hosobe S; Miura K; Bandyopadhyay S; Gross SC; Balaji KC; Watabe K
    Genes Chromosomes Cancer; 2001 Sep; 32(1):33-42. PubMed ID: 11477659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu X; An Q; Zhang J; Tang P; Cheng S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer.
    Elo JP; Härkönen P; Kyllönen AP; Lukkarinen O; Poutanen M; Vihko R; Vihko P
    Cancer Res; 1997 Aug; 57(16):3356-9. PubMed ID: 9269995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
    Bova GS; Carter BS; Bussemakers MJ; Emi M; Fujiwara Y; Kyprianou N; Jacobs SC; Robinson JC; Epstein JI; Walsh PC
    Cancer Res; 1993 Sep; 53(17):3869-73. PubMed ID: 7689419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
    Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
    Wu YQ; Chen H; Rubin MA; Wojno KJ; Cooney KA
    Cancer Res; 2001 Dec; 61(24):8651-3. PubMed ID: 11751379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular studies of loss of heterozygosity in Chinese sporadic retinoblastoma patients.
    Zhang XL; Fu WL; Zhao HX; Zhou LX; Huang JF; Wang JH
    Clin Chim Acta; 2005 Aug; 358(1-2):75-80. PubMed ID: 15921673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer.
    Nakanishi H; Wang XL; Imai FL; Kato J; Shiiba M; Miya T; Imai Y; Tanzawa H
    Anticancer Res; 1999; 19(1A):29-34. PubMed ID: 10226521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of two distinct deleted regions on chromosome 13 in prostate cancer.
    Li C; Larsson C; Futreal A; Lancaster J; Phelan C; Aspenblad U; Sundelin B; Liu Y; Ekman P; Auer G; Bergerheim US
    Oncogene; 1998 Jan; 16(4):481-7. PubMed ID: 9484837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers.
    Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J
    Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.